Literature DB >> 3020290

Viral conjunctivitis with special reference to adenovirus type 37 and enterovirus 70 infection.

K Aoki, R Kawana, I Matsumoto, G Wadell, J C de Jong.   

Abstract

The clinical and etiological findings in 727 patients with viral conjunctivitis treated from January 1982 through December 1984 at Aoki Eye Clinic in Sapporo, Japan, were presented. The age of the patients ranged from 11 days to 88 years, and the monthly incidences of the disease from 18 to 131 cases, with a clustering in the summer season. The etiological diagnosis was established in 399 (54.9%) of the 727 patients: adenovirus (Ad) 3 in 45 cases; Ad4 in 98 cases; Ad8 in 57 cases; Ad19 in 23 cases; Ad37 in 51 cases; untyped Ad in 33 cases; enterovirus (EV) 70 in 60 cases; herpes simplex virus type I in 24 cases and varicella-zoster virus in 4 cases. The clinical pictures of adenovirus 37 conjunctivitis were generally similar to those of adenovirus 8 conjunctivitis, and subconjunctival hemorrhage was more frequently seen in cases of EV70 conjunctivitis. EV70 cases showed nosocomial infection. In addition to Ad8, Ad37 seems to play an important role as a causative agent of epidemic keratoconjunctivitis in Japan.

Entities:  

Mesh:

Year:  1986        PMID: 3020290

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  10 in total

1.  Adenovirus strains of subgenus D associated with nosocomial infection as new etiological agents of epidemic keratoconjunctivitis in Japan.

Authors:  S Takeuchi; N Itoh; E Uchio; K Tanaka; N Kitamura; H Kanai; K Isobe; K Aoki; S Ohno
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

2.  Spread of epidemic keratoconjunctivitis due to a novel serotype of human adenovirus in Japan.

Authors:  Hiroaki Ishiko; Koki Aoki
Journal:  J Clin Microbiol       Date:  2009-08       Impact factor: 5.948

3.  Rapid diagnosis of adenoviral conjunctivitis by PCR and restriction fragment length polymorphism analysis.

Authors:  W Saitoh-Inagawa; A Oshima; K Aoki; N Itoh; K Isobe; E Uchio; S Ohno; H Nakajima; K Hata; H Ishiko
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

4.  Serotyping of adenoviruses on conjunctival scrapings by PCR and sequence analysis.

Authors:  S Takeuchi; N Itoh; E Uchio; K Aoki; S Ohno
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

5.  The degree of genetic variability among adenovirus type 4 strains isolated from man and chimpanzee.

Authors:  Q G Li; G Wadell
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

6.  Clinical and epidemiological features of acute follicular conjunctivitis with special reference to that caused by herpes simplex virus type 1.

Authors:  E Uchio; S Takeuchi; N Itoh; N Matsuura; S Ohno; K Aoki
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

7.  Molecular diagnosis of human adenoviruses d and e by a phylogeny-based classification method using a partial hexon sequence.

Authors:  Yasushi Shimada; Toshihide Ariga; Yoshitsugu Tagawa; Koki Aoki; Shigeaki Ohno; Hiroaki Ishiko
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Epidemic keratoconjunctivitis due to the novel hexon-chimeric-intermediate 22,37/H8 human adenovirus.

Authors:  Koki Aoki; Hiroaki Ishiko; Tsunetada Konno; Yasushi Shimada; Akio Hayashi; Hisatoshi Kaneko; Takeshi Ohguchi; Yoshitsugu Tagawa; Shigeaki Ohno; Shudo Yamazaki
Journal:  J Clin Microbiol       Date:  2008-08-13       Impact factor: 5.948

9.  Antigenic relationships among the 47 human adenoviruses determined in reference horse antisera.

Authors:  J C Hierholzer; Y O Stone; J R Broderson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

10.  Outbreak of epidemic keratoconjunctivitis caused by human adenovirus type 56, China, 2012.

Authors:  Guohong Huang; Wenqing Yao; Wei Yu; Lingling Mao; Haibo Sun; Wei Yao; Jiang Tian; Ling Wang; Zhijian Bo; Zhen Zhu; Yan Zhang; Zhuo Zhao; Wenbo Xu
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.